Under the terms of the arrangement, GVK Biosciences and Excel will help sponsors conduct and manage Phase II-IV clinical trials, statistical analysis and medical writing. Any India trial for Excel will be carried out by the GVK Biosciences clinical research team and will be managed by a core project management team of Excel. Similarly, a GVK Biosciences China trial will be carried out by the Excel team and managed by GVK Biosciences’s project management team.
The alliance provides clinical trial sponsors access to the scientific skills, talent pool, flexible resourcing, and cost-effectiveness of both India and China, said GVK Biosciences. Through the GVK Biosciences-Excel alliance sponsors will be able to conduct Phase II-IV trials using India and China as required with speed and efficiency.
GVK Biosciences said that it has recently strengthened its team by hiring Shoibal Mukherjee as its clinical development head. The company also added new services in pharmacovigilance and medical writing operating from its clinical research facility in Gurgaon, India.
Manni Kantipudi, president of GVK Biosciences, said: “This is a first of a kind alliance between an Indian clinical research organization (CRO) and a Chinese CRO. The GVK Biosciences-Excel alliance integrates trial management across India and China and provides sponsors with a single point of contact.”